Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma

Young-Chan WI; Ahrim MOON; Min-Jung JUNG; Yeseul KIM; Seong-Sik BANG; Kiseok JANG; Seung-Sam PAIK; Su-Jin SHIN.
Journal of Pathology and Translational Medicine ; : 378-385, 2018.
Artículo en Inglés | WPRIM | ID: wpr-741202

Documentos relacionados

  1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  2. Molecular differences in renal cell carcinoma between males and females.
  3. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
  4. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
  5. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
  6. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
  7. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  8. Heavy Metal Enlightens Tumor Immunity.
  9. Heterogeneity of Hippo signalling activity in different histopathologic subtypes of renal cell carcinoma.
  10. Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.